AU1189201A - Therapeutic compositions including protein kinase c inhibitors - Google Patents

Therapeutic compositions including protein kinase c inhibitors

Info

Publication number: AU1189201A
Authority: AU; Australia
Prior art keywords: inhibitors; protein kinase; therapeutic compositions; compositions including; including protein
Prior art date: 1999-10-22
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU11892/01A

Inventor

Norman Eugene Cameron

Douglas Kirk Ways

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Eli Lilly and Co

Original Assignee

Eli Lilly and Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-22

Filing date

2000-10-13

Publication date

2001-05-08

2000-10-13 Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co

2001-05-08 Publication of AU1189201A publication Critical patent/AU1189201A/en

Status Abandoned legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Diabetes (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU11892/01A 1999-10-22 2000-10-13 Therapeutic compositions including protein kinase c inhibitors Abandoned AU1189201A (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US16112999P	1999-10-22	1999-10-22
US60161129		1999-10-22
US17751000P	2000-01-21	2000-01-21
US60177510		2000-01-21
PCT/US2000/026254 WO2001030331A2 (en)	1999-10-22	2000-10-13	Therapeutic compositions including protein kinase c inhibitors

Publications (1)

Publication Number	Publication Date
AU1189201A true AU1189201A (en)	2001-05-08

Family

ID=26857534

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU11892/01A Abandoned AU1189201A (en)	1999-10-22	2000-10-13	Therapeutic compositions including protein kinase c inhibitors

Country Status (2)

Country	Link
AU (1)	AU1189201A (en)
WO (1)	WO2001030331A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2001271261A1 (en) *	2000-06-29	2002-01-14	Eli Lilly And Company	Therapeutic treatment of cancer with a protein kinase c inhibitor
AU2001271257A1 (en) *	2000-06-29	2002-01-14	Eli Lilly And Company	Use of a protein kinase c inhibitor to enhance the clinical efficacy of anti-neoplastic chemotherapeutic agents and radiation therapy
CA2393720C (en) *	2002-07-12	2010-09-14	Eli Lilly And Company	Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
GB0303319D0 (en)	2003-02-13	2003-03-19	Novartis Ag	Organic compounds
CN1787824A (en) *	2003-06-25	2006-06-14	有限会社循环器研究所	External preparation for improving coital function
US20060281787A1 (en) *	2003-10-24	2006-12-14	Graff Jeremy R	Bisindolyl maleimides useful for treating prostate cancer and akt-mediated diseases
US20080096923A1 (en) *	2004-07-23	2008-04-24	Aniz Girach	Methods For Diagnosing And Treating Diabetic Microvascular Complications
EP1621201A1 (en) *	2004-07-28	2006-02-01	NeuroCode AG	Hesperidin for prophylaxis and treatment of diseases of the central nervous system, in particular Alzheimer's and Parkinson's diseases, for therapy after stroke as well as for chronic pain.
DE502005002104D1 (en) *	2005-05-13	2008-01-10	Mewicon Med Wiss Beratung Gmbh	Hesperidin for the treatment of epilepsy
US8785648B1 (en)	2010-08-10	2014-07-22	The Regents Of The University Of California	PKC-epsilon inhibitors
EA026431B1 (en)	2012-03-16	2017-04-28	Вайтаи Фармасьютиклз, Инк.	Liver x receptor modulators
JP6114814B2 (en)	2012-03-16	2017-04-12	ヴァイティーファーマシューティカルズ，インコーポレイテッド	Liver X receptor modulator
EP3180003B1 (en)	2014-07-01	2022-01-12	The Regents of the University of California	Pkc-epsilon inhibitors
RU2742030C1 (en) *	2020-06-11	2021-02-01	Общество с ограниченной ответственностью "ЦитоНИР" (ООО "ЦитоНИР")	Hesperidine conjugate and method for preparation thereof

2000
- 2000-10-13 AU AU11892/01A patent/AU1189201A/en not_active Abandoned
- 2000-10-13 WO PCT/US2000/026254 patent/WO2001030331A2/en active Application Filing

Also Published As

Publication number	Publication date
WO2001030331A2 (en)	2001-05-03
WO2001030331A3 (en)	2002-01-24

Similar Documents

Publication	Publication Date	Title
AU2437900A (en)	2000-08-07	Piperidinylquinolines as protein tyrosine kinase inhibitors
AU2728201A (en)	2001-07-03	4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
HUP0202490A3 (en)	2003-01-28	Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
IL148719A0 (en)	2002-09-12	Kinase inhibitors as therapeutic agents
AU6411698A (en)	1998-10-12	Substituted 2-anilinopyrimidines useful as protein kinase inhibitors
AU5173400A (en)	2000-12-18	Protein kinases
AU2002310187A1 (en)	2002-12-09	Inhibitors of protein kinase for the treatment of disease
IL148614A0 (en)	2002-09-12	Pteridinones as kinase inhibitors
HUP0202897A3 (en)	2004-12-28	Diaminothiazoles and their use for inhibiting protein kinases and pharmaceutical compositions containing them
AU2001268154A1 (en)	2001-12-17	Indolinone derivatives as protein kinase/phosphatase inhibitors
AU2001270260A1 (en)	2002-01-14	4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
AU5326100A (en)	2000-12-28	Pharmaceutical compositions and methods for use
AU3556400A (en)	2000-10-04	Pharmaceutical compositions
AU2001245987A1 (en)	2001-10-08	Compositions and methods for gene therapy
AU1189201A (en)	2001-05-08	Therapeutic compositions including protein kinase c inhibitors
AU2576501A (en)	2001-06-18	Protein kinase inhibitors
AU2187301A (en)	2001-06-25	Protein kinase regulation
AU6460400A (en)	2001-03-13	Pharmaceutical compositions
AU2002365093A1 (en)	2003-07-09	Therapeutic compositions
AU3235100A (en)	2000-09-04	Prothease inhibitors
AU4188500A (en)	2000-11-17	Protein c derivatives
AUPR600601A0 (en)	2001-07-26	Therapeutic compositions
AU6460200A (en)	2001-03-13	Pharmaceutical compositions
AU2591299A (en)	1999-09-15	Human protein kinase c inhibitor
AU5836700A (en)	2000-12-18	Peptides for therapeutic use

Legal Events

Date	Code	Title	Description
2002-06-20	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase